【4502】武田薬品工業 : Takeda Submits New Drug Applications in Japan for Cell Culture-Based Pandemic Influenza Vaccines with its Hikari Plant

Takeda Submits New Drug Applications in Japan for Cell Culture-Based Pandemic Influenza Vaccines with its Hikari Plant

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード